FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells
Authors:
- Huiming WangHWHuiming Wang
- Lin ZhouLZLin Zhou
- Da YuDYDa Yu
- 1 February 2011
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 251 (1) , 8-15
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Synergistic effect of rapamycin and cisplatin in endometrial cancer cellsCancer, 2009
- FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cellsMolecular Cancer Therapeutics, 2008
- Unravelling the tumor-suppressive functions of FOXO proteinsTrends in Cell Biology, 2008
- A Retroinhibition Approach Reveals a Tumor Cell–Autonomous Response to Rapamycin in Head and Neck CancerCancer Research, 2008
- Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and NeckCancer Research, 2005
- Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27 KIP1Molecular and Cellular Biology, 2000
- Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1Current Biology, 2000
- Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription FactorCell, 1999
- Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene TherapiesJNCI: Journal of the National Cancer Institute, 1998
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984